Latest Business Development News

Oakridge International Limited reported strong operational and financial progress for Q1 2025, highlighting increased trading income, positive cash flow, and a robust sales pipeline in healthcare IoT technology despite ongoing legal discussions.

SQX Resources has integrated new drilling data with historical exploration to refine its gold and copper targets at Scrub Paddock and Ollenburgs, while maintaining a solid cash position of $1.64 million.

Altair Minerals has made a significant leap with the acquisition of the Venatica Copper Project in Peru, revealing multiple high-grade porphyry systems that could position the company as a key player in a globally significant copper belt.

Stonehorse Energy’s Q1 2025 report reveals Canadian wells outperforming production forecasts while revenue dips due to softer commodity prices. US operations show recovery, and the company intensifies Canadian business development amid market volatility.

Lunnon Metals Limited has showcased significant progress in its gold and nickel exploration projects, highlighting strong drilling results and development plans for the Lady Herial gold deposit and Baker-Foster nickel resources.

4DS Memory Limited has successfully manufactured its first 20nm memory cell array, marking a pivotal step in its ReRAM technology development, while raising $8.6 million through a placement and Share Purchase Plan to fuel ongoing innovation.

Australian Bond Exchange Holdings (ASX: ABE) reported a strong $3.6 billion trading volume for Q3 FY25 and announced a strategic partnership with ViewTrade Australia, while securing $1.8 million in funding to support its growth trajectory.

Ronin Resources has made significant strides in its La Punilla gold-silver project in Argentina, while navigating socio-political hurdles in Colombia and refining its lithium exploration efforts in Canada. The company maintains a solid cash position as it pursues new business opportunities.

Patrys Limited advances its PAT-DX3 therapy development for inflammatory diseases while navigating cash flow challenges and pursuing partnerships to sustain operations.

Cosmo Metals has completed the acquisition of the Bingara and Nundle gold-antimony-copper projects in NSW and progressed exploration at its Kanowna Gold Project in WA, supported by a $1.1 million capital raise.

PainChek Limited reports strong progress toward FDA De Novo clearance for US market entry, launches its Infant App in Australia, and achieves robust global licence growth with a 30% year-on-year revenue increase.

Island Pharmaceuticals has completed dosing in the Phase 2b cohort of its dengue fever trial, with pharmacokinetic targets met and top-line results expected next month. The company also strengthened its balance sheet by raising $1.94 million through option exercises.